Risk of cancer in patients with psoriasis on biological therapies: a systematic review
British Journal of Dermatology2017Vol. 178(1), pp. 103–113
Citations Over TimeTop 10% of 2017 papers
Abstract
There were important limitations to the studies identified including choice of comparator arms, inadequate adjustment for confounding factors and failure to account for latency periods of cancer. There remains a need for ongoing pharmacovigilance in relation to cancer risk and biological therapy; the NMSC signal requires further investigation to determine the risk specifically attributable to biological therapy using prospectively collected data with adjustment for known NMSC risk factors.
Related Papers
- → A case of psoriasis treatment using psorinum autonosode(2023)1 cited
- → Psoriasis(2010)2 cited
- Expression and function of serum soluble CD147 in patients with psoriasis(2014)
- The detection and clinical significance of the PDEs activities in psoriasis patients(2012)
- A Case of Photosensitive Psoriasis Initiated by Sun Exposure(2002)